Clinical Trial Update: Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT

View source ↗

Summary

A clinical trial evaluating 18F-FluorThanatrace PET/CT imaging for primary or recurrent breast cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Pennsylvania | Conditions: Breast Cancer | Status: ACTIVE_NOT_RECRUITING